miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-␣ activation TUBULOINTERSTITIAL FIBROSIS (TIF) is the common pathway in the progression of chronic kidney disease (CKD), leading to functional deterioration and eventual loss of renal function, irrespective of the nature of the initial renal injury (5, 10, 19, 36) . Tubulointerstitial ischemia or hypoxia has been proposed as a pivotal microenvironmental factor in the development of renal fibrosis (47) . The molecular mechanisms mediating responses to hypoxia are complex, with hypoxia-inducible factor (HIF) playing a key role (32) . Regulation of HIF occurs mainly through oxygen-dependent destruction of its ␣-subunit. In the presence of oxygen, two ␣-prolyl residues undergo enzymatic hydroxylation, which is required for its proteasomal degradation. Pharmacological activation of HIF-␣ could be achieved in an oxygen-independent manner by using prolyl 4-hydroxylase (PHD) inhibitors such as L-mimosine (L-Mim) (23) .
MicroRNAs (miRNAs) are small regulatory RNA molecules encoded by specific genes in plant and animal genomes (8, 9, 24, 29, 33) . Typically, miRNAs bind to the 3=-untranslated region (UTR) of target mRNAs and decrease the abundance of target proteins. The effect may be mediated by translational repression and/or decreases in mRNA abundance. Several miRNAs have been shown to be involved in the development of kidney disease, including renal interstitial fibrosis (2, 20, 28) . HIF plays an important role in regulating the expression of a subset of hypoxiarelated microRNAs (HRM), providing additional links between HIF and gene expression control. However, it is not known whether HIF regulation of miRNAs is involved in kidney disease, including renal interstitial fibrosis.
We have shown in previous studies that pimonidazole, which serves as an indicator of hypoxic cells, was detected in remnant kidneys soon after renal mass reduction, from the outer medulla to the cortex. The adduction value reached the peak at weeks 4 and 6 and decreased thereafter. Simultaneously, there was transient HIF-␣ activation in the remnant kidney of rats at the early stage following subtotal nephrectomy, which also peaked at weeks 4 and 6. L-Mim administered in later stages reactivated HIF-␣ and ameliorated the progression of CKD and renal interstitial fibrosis (56, 57) . In the present study, we found the abundance of a miRNA, miR-29c, which is known to suppress the expression of extracellular matrix genes (22) , was decreased in the rat remnant kidney model as well as in human kidneys with TIF from IgA nephropathy patients. In vivo and in vitro experiments demonstrated a novel role of HIF-␣ in upregulating miR-29c expression.
MATERIALS AND METHODS

Experimental animal protocol.
All experiments were performed in male Sprague-Dawley rats, weighing 180 -200 g, obtained from the Animal Centre, Shanghai Medical College, Fudan University (Shanghai, China). Rats were allowed free access to water and rodent food. All protocols were approved by the Institutional Animal Care and Use Committee of Fudan University.
Approximately two-thirds of the left kidney were removed by abdominal resection of the upper and lower thirds of the kidney. One week later, a right nephrectomy was performed through a translumbar route. All the surgical procedures were carried out under general anesthesia (pentobarbital sodium, 40 mg/kg ip). Four weeks after 5 ⁄6 nephrectomy, rats were treated with intraperitoneal injections of vehicle or L-Mim (Calbiochem), an inhibitor of PHD activity (12, 17) , at a dosage of 50 mg/kg every other day. Rats without kidney resection served as the sham-operated group. At the end of week 12 after 5 ⁄6 nephrectomy, all rats (n ϭ 8/group) were euthanized and blood samples were collected via cardiac puncture. Renal tissue was harvested, one piece of which was fixed in neutral formalin and then embedded in paraffin. The remaining kidney tissue was dissected in ice-cold PBS to remove the medulla and then snap-frozen in liquid nitrogen before transferance to storage at Ϫ80°C until further analysis.
Cell culture and transforming growth factor-␤1 treatment. HK-2, a human kidney epithelial cell line, was obtained from and cultured as suggested by American Type Culture Collection (48, 49) . Cells at ϳ40% confluence were treated with recombinant human transforming growth factor (TGF)-␤1 (3 ng/ml, R&D Systems) or the vehicle control in DMEM for the indicated time period.
Patient selection and renal morphological analyses. We studied 10 patients with primary IgA nephropathy confirmed by kidney biopsy in Zhongshan Hospital, Fudan University, between 2009 and 2010, five with no TIF and five with moderate to severe TIF. Analysis of renal fibrosis was performed with 2-m paraffin-embedded sections stained by periodic acid-Schiff (PAS) or Masson trichrome. The degree of renal fibrosis was scored by an experienced pathologist. The degree of glomerulosclerosis was represented by the percentage of sclerotic glomeruli in total glomeruli obtained from biopsy (42) . For TIF, 10 microscopic fields were viewed at a magnification of ϫ200 and scored subjectively from 0 to 100% for each patient. The degree of TIF was graded on a scale of 0 -4: grade 0, affected area 0% (normal); grade 1, affected area Ͻ10%; grade 2, affected area 10 -25%; grade 3, affected area 25-75%; grade 4, affected area Ͼ75% (30). The resulting index in each slide was expressed as a mean of all scores obtained. The same method was applied in the analysis of rat renal pathology. The study was approved by the Clinical Research Ethical Committee of the Zhongshan Hospital, Fudan University. All patients provided informed consent. Clinical data including blood pressure, serum creatinine, and 24-h urine protein were recorded at the time of kidney biopsy.
RNA isolation. Total RNA was extracted using TRIzol (Invitrogen) from cells or tissue sections as previously described (3, 15, 21, 27, 48 -50) . Total RNA from formalin-fixed and paraffin-embedded (FFPE) tissue was extracted by using a RecoverALL total nucleic acid isolation kit (Ambion, Austin, TX) according to the manufacturer's protocol.
For microRNA microarray experiments, total RNA was extracted from the tissue samples using a mirVana miRNA isolation kit (Applied Biosystems, Foster City, CA). The concentration was quantified by a NanoDrop 1000 Spectrophotometer (NanoDrop Technologies, Waltham, MA). The quality check of RNA was performed using a 2100 Bioanalyzer with an RNA 6000 Pico LabChip kit (Agilent Technologies, Santa Clara, CA). An RNA integrity number (RIN) score was generated for each sample on a scale of 1-10 as an indication of RNA quality (15, 21, 27, 45) . The quality is considered to be excellent for RIN м 7-10, good for RIN м 5, and poor for RIN Ͻ5. We took 5.5 as the cutoff in our study.
miRNA expression profiling. Rat miRNA microarrays (Agilent Technologies) were used to compare the expression profiles in the remnant rat kidneys from the vehicle-treated rats (n ϭ 4) and the L-Mim-treated rats (n ϭ 4). The microarray contains probes for 350 rat miRNAs from the Sanger database v.10.1. Total RNA (100 ng) derived from each of the renal samples was used as inputs for labeling via Cy3 incorporation. Microarray slides were scanned by XDR Scan (PMT100, PMT5). The labeling and hybridization were performed at Shanghai Biochip according to the protocols in the Agilent miRNA microarray system.
The microarray image information was converted into spot intensity values using Scanner Control Software Rev. 7.0 (Agilent Technologies). The signal after background subtraction was exported directly into the GeneSpring GX10 software (Agilent Technologies) for quantile normalization. The mean normalized signal from biological replicates was used for comparative expression analysis. An unpaired t-test with Benjamini-Hochberg correction was used to identify differentially expressed miRNAs between the vehicle-and the L-Mim-treated rats. Fold-changes in expression signals between the two groups were calculated from the normalized values. The criteria of differential expression were P Ͻ 0.05, signal difference Ͼ150, and fold-change Ͼ200%. The overall, permutation-based false positive rate was 20%.
Taqman real-time PCR. Expression levels of miR-29 family and pri-miR-29c were quantified using real-time PCR with Taqman chemistry (Applied Biosystems) as described previously (27, 50) . mRNA level of tropomyosin 1␣ (TPM1), HIF-1␣, and HIF-2␣ were quantified using SYBR Green chemistry as described previously (21, 31) . Total RNA samples were used in these analyses. 5S and 18S rRNA were used as internal normalizers for miRNA and protein-coding genes, respectively. The primer set (5=-3=) for rat TPM1 was cgagcccaaaaagatgaagaaa (forward) and cctccgcacgctccagat (reverse), for human HIF-1␣ was TCTTTTACCATGCCCCAGATTC (forward) and ATTAGGCTCAGGTGAACTTTGTCTAGT (reverse), and for human HIF-2␣ was TCGTCAGCCCACAAGGTGTC (forward) and GGCACGTTCACCTCACAGTCA (reverse).
Western blotting and immunohistochemistry. The relative abundance of several proteins was analyzed using Western blotting or immunohistochemistry (IHC) as we described previously (3, 16, 21, 27, 48, 53) . Antibodies were from Sigma-Aldrich, Abcam, Novus Biologicals, Bioworld, or Jackson ImmunoResearch.
3=-UTR reporter analysis. 3=-UTR reporter constructs were generated and reporter activity was analyzed as we described previously with minor modification (21, 27) (Table 1) . Briefly, HeLa cells at 80 -90% confluency were cotransfected with a 3=-UTR reporter construct (100 ng/well), a pRL-TK internal control plasmid (50 ng/well), and control pre-miR oligonucleotides or the miR-29c mimic (10 pmol/well, Ambion), using Lipofectamine 2000 (Invitrogen) following Invitrogen's protocol. At 24 h after the transfection, firefly and Renilla luciferase activities in each well were measured using the Dual-Luciferase Reporter Assay System (Promega) following the manufacturer's protocol for microplate assay. Renilla luciferase activity was used to normalize luciferase activity to control for transfection efficiency and cell density.
Site-directed mutagenesis was performed with a QuickChange II XL Site-Directed Mutagenesis Kit (Stratagene), following the protocol suggested by the manufacturer. Primers used for introducing point mutations for rat collagen II ␣1 (COL2a1) are forward: 5-GTGTGTCCTACA-CAATGGTCGTATTCTGTGTCAAACACC-3 and reverse: 5-GGT-GTTTGACACAGAATACGACCATTGTGTAGGACACAC-3. Primers used for introducing point mutations for raTPM1 are forward: 5-GACAATCAGGTGCAGATTGGTCGTAATTTAAACAAAA-GAACCCC-3 and reverse: 5-GGGGTTCTTTTGTTTAAATTACGAC-CAATCTGCACCTGATTGTC-3. Underlined nucleotides represent the mutations introduced, which all lie in the core region of the predicted target site of miR-29c.
Small interfering RNAs and transfection. Small interfering RNA (siRNA) sequences against HIF-1␣, HIF-2 ␣, and HIF-1␣ scram- The position numbers are relative to the first nucleotide in the 3=-untranslated region (UTR) or the first nucleotide after TAA/TGA stop codon. TPM1, tropomyosin; COL2A1, collagen type II ␣1; miR, microRNA. bled control were designed and synthesized by GenePharma (A01010, GenePharma, Shanghai, China). siRNAs were transfected using DharmaFECT 1 (Dharmacon). In brief, cells were cultured in a six-well plate to 50% confluence. For each well, 100 l siRNAs (2 M) was added into 100 l Opti-MEM medium (GIBCO BRL), 2 l DharmaFECT 1 into 198 l Opti-MEM medium, and then mixed siRNA with DharmaFECT 1 after a 5-min incubation. After 20 min, the culture medium was removed from the wells of the six-well plate and the transfection mixture (400 l) and another 1,600 l Opti-MEM were added to each well, with the target 100 nM siRNAs. Total RNA and protein were prepared 24 or 48 h after transfection and were used for qRT-PCR or Western blot analysis.
Pre-miR oligonucleotides. Pre-miR oligonucleotides were obtained from Ambion. HK2 cells were transfected with pre-miR (100 nM) using Oligofectamine (Invitrogen).
Statistical analysis. Data were analyzed using Student's t-test and multiple-group analysis of variance, except the microarray experiment described above. P Ͻ 0.05 was considered significant. Data are shown as means Ϯ SD.
RESULTS
miRNA profiles in the renal cortex of 5 ⁄6 nephrectomized rats treated with L-Mim or vehicle.
In our previous studies, we found that chronic renal damages developed progressively in rats with 5 ⁄6 nephrectomy and that L-Mim intervention from week 5 to week 12 resulted in additional accumulation of HIF-1␣ and -2␣ at week 12 and improved renal function (56) . To explore the role of microRNAs in this renoprotective phenomenon, we compared microRNA expression profiles in rats with 5 ⁄6 nephrectomy treated with L-Mim or vehicle (GEO accession no. GSE28471). The abundance of 350 miRNAs in the remnant renal cortex was examined with miRNA microarrays in both groups. Nine miRNAs were considered differentially expressed between the L-Mim-treated and the vehicletreated remnant kidneys 12 wk after surgery. Rno-miR-130b, rno-miR-450a, rno-872, rno-miR-24, and rno-miR-25 were expressed at lower levels in the L-Mim-treated group, while rno-miR-29c, rno-miR-29c*, rno-miR-22*, and miR-345-5p were higher in the L-Mim-treated group (Fig. 1A) .
Taqman real-time PCR analysis in RNA samples independent of those used in the microarray experiment indicated that miR-29c was significantly downregulated in the remnant kidney and significantly restored by the L-Mim treatment, the latter confirming the finding in the miRNA microarray experiment (Fig. 1B) . miR-29a and miR-29b, two other members of the miR-29 family, also tended to be downregulated in the remnant kidney and restored by L-Mim, but the differences did not reach statistical significance (Fig. 1B) . Moreover, the L-Mim treatment resulted in significant upregulation of the primary transcript pri-miR-29b2/c (Fig. 1C) .
The nuclear expression of HIF-␣ was upregulated in the early stage after 5 ⁄6 nephrectomy when renal function was stable and returned to the basal level later, accompanied by impaired renal function and interstitial fibrosis (56) . During the same progression time course in the remnant kidney model, abundance of miR-29c was decreased at week 2 and gradually restored from week 4 to week 6, coinciding with the peak of HIF-␣ upregulation. miR-29c abundance remained lower than the baseline level from week 8 to week 12, even though it did not decline again as HIF-␣ did (Fig. 1D) .
Activation of HIF-␣ upregulated miR-29c expression. We examined in cultured human kidney epithelial HK2 cells whether miR-29c was regulated by HIF-␣. Treatment of HK2 cells with CoCl 2 , a potent stimulator of HIF-␣, significantly upregulated miR-29c ( Fig. 2A) . The upregulation of miR-29c was significantly attenuated when the cells were transfected with siRNA targeting HIF-1␣ or HIF-2␣ compared with negative control siRNA ( Fig. 2A) . mRNA and protein levels of HIF-1␣ and HIF-2␣, which were increased substantially by the CoCl 2 treatment, were significantly and substantially reduced by corresponding siRNA (Fig. 2, B-D) . In addition, pretreating cells with CoCl 2 upregulated the abundance of pri-miR-29b2/c (Fig. 2E) .
miR-29c expression was inversely correlated with renal interstitial fibrosis in the rat remnant kidney and in humans.
The miR-29 family has been shown to suppress the expression of a large number of collagens and genes related to the extra- cellular matrix (ECM) in several diseases (22) , including renal interstitial fibrosis (27, 39) . Substantial renal interstitial fibrosis developed in the rat remnant kidney, in which miR-29c was suppressed (Fig. 3) . The L-Mim treatment significantly attenuated interstitial fibrosis in the remnant kidney, concomitant with restoration of miR-29c expression (Fig. 3 ).
The inverse relationship between miR-29c expression and renal interstitial fibrosis also exists in patients. A group of IgA nephropathy patients was selected to include cases with minimal or substantial renal interstitial fibrosis (Table 2 and Fig. 4 , A and C). RNA samples were extracted from paraffin blocks of the patients' biopsies. Real-time PCR analysis showed that miR-29c abundance was significantly lower in IgA nephropathy patients with substantial renal interstitial fibrosis (Fig. 4E) . HIF-1␣ protein was clearly present in both groups (IgAN with TIF and IgAN without TIF), and nuclear staining of HIF-1␣ was comparatively weak or negative in most proximal tubules and atrophied distal tubules. The staining was upregulated in the dilated tubules or tubules surrounded by inflammatory cells, suggesting a potential hypoxia stimulus existing in the involved live tubules. The comparative abundance of positive HIF-1␣ staining was higher in the group of IgAN without TIF compared with IgAN with TIF (Fig. 4, B and D, Table 2 ), which might be attributed to the decreased number of tubules in the TIF area.
Identification of TPM1 and COL2A1 as new targets of miR-29c. Identification of target genes is the most critical step in understanding the mechanism mediating the effect of a miRNA. miR-29c is known to target and suppress several extracellular matrix genes (22) . We set out to identify additional targets of miR-29c. TPM1 and COL2A1 were predicted targets of miR-29c based on TargetScan v5.1 (http://www.targetscan.org/) and MicroCosm Targets v5 (http://www.ebi.ac.uk/enright-srv/ microcosm/htdocs/targets/v5/), but were not yet confirmed. Western blot analysis of TPM1 showed that the renal cortical protein abundance of TPM1 was substantially upregulated in the rat remnant kidney and significantly attenuated by the L-Mim treatment (Fig. 5A) . Immunohistochemical analyses showed that TPM1 staining was significantly higher in the kidneys of IgA nephropathy patients with substantial interstitial fibrosis (Fig. 5B) . COL2A1-positive areas were significantly increased in the rat remnant kidney or in the kidneys of IgA nephropathy patients with substantial interstitial fibrosis (Fig. 6) . Staining of COL2A1 was diffuse. We only chose renal interstitial regions for comparison, and the stained regions were thresholded using the computeraided image system (IMS; ShentengIT, Shanghai, China). The L-Mim treatment reduced COL2A1-positive areas in the rat remnant kidney (Fig. 6 ). These changes in TPM1 and COL2A1 expression were inversely correlated with miR-29c expression as described above.
3=-UTR reporter analysis was performed to directly examine the 3=-UTR-mediated interaction between miR-29c and TPM1 IgA nephropathy showing subjects with or without substantial interstitial fibrosis. Each field was 72,800 m 2 , magnification ϫ200. B: immunohistochemical analysis for HIF-1␣ abundance in renal biopsy specimens from IgA nephropathy (IgAN) patients. HIF-1␣ protein was present in both group (brown nuclear staining represents positive HIF-1␣ staining; black arrows). Magnification ϫ100. C: positive trichrome-stained areas were quantified as described in Fig. 3 . D: positive HIF-1␣-stained areas were quantified as described in Fig. 3 . E: miR-29c abundance was decreased in kidneys with a high degree of interstitial fibrosis from patients with IgAN; TIF, tubulointerstitial fibrosis. *P Ͻ 0.05 vs. IgAN without TIF. #P Ͻ 0.01 vs. IgAN without TIF; n ϭ 5. and COL2A1 (Table 1 ). The miR-29c mimic, compared with a control miRNA mimic, significantly reduced COL2A1 and TPM1 3=-UTR activity by 39.5 and 31.5%, respectively. The miR-29c mimic did not have significant effects on mutated 3=-UTRs of COL2A1 and TPM1 (Ϫ17.9 and Ϫ19.6%, respectively) (Fig. 7) .
miR-29c suppressed TPM1 expression in cultured HK2 cells treated with TGF-␤1. We performed additional studies on TPM1 because TPM1 is known to be involved in stress fiber function, and in our previous study in HK2 cells protein expression of TPM1 was found to be upregulated in a time-dependent manner after TGF-␤1 treatment (21) . TGF-␤1 significantly reduced miR29c expression in HK2 cells (Fig. 8A) , which was restored by pretreatment with CoCl 2 (200 M) (Fig. 8B) . Real-time RT-PCR analysis indicated that TPM1 mRNA levels were not altered by the transfection of the miR-29c mimic. However, Western blot analysis showed that the miR-29c mimic, compared with control pre-miR, significantly reduced protein levels of TPM1 by 19.6% (n ϭ 5, P Ͻ 0.05) (Fig. 8C) .
DISCUSSION
In the present study, we identified a novel role of HIF-␣ in upregulating miR-29c expression. We found that the expression of miR-29c was downregulated in renal interstitial fibrosis in rats and humans and restored by HIF-␣ activation. Moreover, we identified TPM1 and COL2A1 as new target genes for miR-29c.
The experimental model of 5 ⁄6 nephrectomy or the remnant kidney model represents one of the most widely used animal models of progressive renal failure by reduced nephron number best characterized in rats (55) . In our previous studies, we found that activation of HIF-␣ was dynamic during the disease progression in the remnant kidney model of CKD, which was activated transiently in the early stage and suppressed in the later stage; inhibition of PHDs using L-Mim activated HIF-␣ and attenuated the progression of CKD in the 5 ⁄6 nephrectomy model in a time-dependent manner (56) . The renoprotective effect of the L-Mim treatment might be attributed to selective upregulation of renoprotective HIF target genes and/or downregulation of injurious genes at appropriate time points during disease progression. The number of reported HIF target genes is Ͼ100. The mechanism underlying "selective" regulation of renoprotective or injurious genes is not clear (11, 14, 18, 32, 41, 47) . Since selectively activation of HIF-␣ isoforms might partially contribute to the complex regulation of HIF-targeted genes (2), hypoxia-regulated microRNAs appeared particularly The positively stained area of COL2A1 protein was quantified as described in Fig. 3 . Only the renal interstitial area was selected for analysis. Stained regions were thresholded using an IMS (ShentengIT). Each field was 72,800 m suitable to serve as hubs of regulatory networks underlying these complex processes (25, 26, 53) . The result of the present study suggests that downregulation of miR-29c could be an important part of the molecular mechanism underlying the development of TIF and CKD in humans and rats and that partial restoration of miR-29c might contribute to L-Miminduced attenuation of CKD progression in the 5 ⁄6 nephrectomy model. This notion is supported by in vivo studies showing that knockdown of a miR-29 family member exacerbated, while overexpression attenuated, renal interstitial fibrosis in rats or mice (27, 39) . It is clearly possible that miR-29c can be regulated by multiple factors and pathways especially in vivo. In this study, the correlation between HIF-␣ and miR-29c in L-Mim-treated rats justified our focus on the HIF-␣ pathway. HIF-1␣ acts by binding to HIF-responsive elements (HREs) in promoters that contain the sequence NCGTG (4, 22) . As shown in Supplemental Fig. 1 (all supplemental material for this article is accessible on the journal website.), in the 2.3-kb promoter region for the rat miR-29b/c gene cluster, there are five NCGTGs, and two of them are very close to the transcription start site (TSS). It would be interesting to further investigate these HIF-responsive elements in future studies. A renoprotective effect of miR-29c would be consistent with the well-established effect of the miR-29 family in targeting extracellular matrix genes (22) . Members of the miR-29 family have been shown to target extracellular matrix genes in the rat kidney, hepatic stellate cells, cardiomyocytes, nasopharyngeal carcinomas, and other tissues (27, 31, 40, 46, 51, 54) . These studies support a key role of the miR-29 family in the control of tissue fibrosis. Targeting of extracellular matrix (ECM) genes by miR-29 is indeed one of the most dramatic and compelling examples of a single microRNA family targeting a large group of functionally related genes (22, 25) . Since only miR-29c reached statistical significance in both our microarray data and real-time PCR results, we focused on miR-29c in this paper. However, the effect of the PHD inhibitor can certainly involve mechanisms other than the miR-29 family.
Besides ECM genes, TPM1 was identified as a new target gene of miR-29c. Tropomyosins are actin-stabilizing proteins consisting of 2 ␣-helical chains arranged as a coiled-coil that bind along the actin filaments and protect them from the binding of actin-destablilizing proteins (38, 44, 46) . Four genes encode multiple isoforms of tropomyosin in a tissue-specific manner with at least 20 different isoforms expressed widely in vertebrates. Fibroblasts and epithelial cells express high-mo- lecular-weight (HMW) tropomyosin isoforms TM2, TM3, and TM6 encoded by the TPM1 gene and TM1 encoded by TPM2. While we have not directly studied the role of TPM1 in fibrosis, TPM1 has been reported as stress fibers that are responsible for ECM deposition (13) and epithelial mesenchymal transformation (EMT) (35, 58) or a biomarker of liver fibrosis (34, 37) and was reported to play an important role in the pathogenesis of endomyocardial fibrosis (6) . In the current study, we used the well-characterized TM311 antibody against tropomyosin, which recognizes up to three bands that presumably correspond to tropomyosin isoforms TM2, TM3, and TM6. In nonmuscle cells, tropomyosins play a role in the formation and stabilization of stress fibers by facilitating actomyosin interactions and protecting existing fibers from the action of severing and deplolymerizing proteins (7, 38, 44) . TGF-␤1 could upregulate HMW tropomyosins, which could enhance actin stress fibers and cell-matrix adhesion but reduce matrix proteolysis (43, 52, 58) . Moreover, suppression of HMW tropomyosins by siRNA in normal cells alleviates TGF-␤1 control of cell motility, and ectopic expression of TM2 and TM3 was sufficient to induce stress fibers, even in the absence of the cytokine (43, 52) . HMW tropomyosin might be one of the critical elements involved in a variety of cytoskeleton-dependent cell functions such as cell migration, as well as controlling the development of polarity and migration of epithelium, or even the process of EMT, in which both TGF-␤1 and stress fibers are involved (43) . Suppression of TPM1 by miR-29c could, therefore, contribute to renal protection. TGF-␤1-dependent downregulation of miR-29c was correlated with increased TM2 or TM3 in vitro. L-Mim-induced miR-29c expression in vivo, however, was mainly correlated with increased TM6. The reason for this discrepancy is unknown.
The effect of HIF activation on CKD is controversial, and the timing of PHD inhibitor administration and isoform-specific effects of HIF-␣ on CKD are complex. The current study suggests that upregulation of miR-29, which targets ECM genes and tropomyosin, might be a more specific candidate for developing future therapeutic tools to prevent or treat renal tubulointerstitial fibrosis.
